Urenco ChemPlants will operate our new Tails Management Facility in the UK, which will deconvert the by-product of enrichment into a more stable form for long term storage for future enrichment or final disposal.
Read moreUrenco Nuclear Stewardship Limited is responsible for the management of nuclear materials, decommissioning and recycling.
Read moreUrenco Stable Isotopes draws on our expertise and capabilities in centrifuge technology to produce stable isotopes for medical, industrial and research applications.
Read moreU-Battery is a conceptual design for a micro modular reactor being developed by a consortium of partners including Urenco.
Read moreOur German enrichment facility is located in Gronau. Its current production capacity is 3,700 tSW/a. Central Technology Group, responsible for enhancing the operation of Urenco’s centrifuge technology, is also based at Urenco Deutschland.
Read moreOur Dutch enrichment facility is located in Almelo. Its current production capacity is 5,200 tSW/a. Our stable isotopes business is also based at Urenco Nederland.
Read moreOur UK enrichment facility is located in Capenhurst. Its current production capacity is 4,500 tSW/a. Our subsidiaries dedicated to overseeing our work in responsible nuclear stewardship are also based at our Capenhurst site.
Read moreOur US enrichment facility is located in Eunice, New Mexico. It is the only operating commercial enrichment facility in the US with a current production capacity of 4,700 tSW/a.
Read more08 August 2022
Today, Urenco publishes its annual Sustainability Report for the year ending 31 December 2021.
Read more05 August 2022
Urenco today announces its results for the half year ended 30 June 2022.
Read more19 July 2022
We've made a donation of £1,500 to an LGBT+ charity and are involved with partners to set up a new community forum for the nuclear industry.
Read more